AGL agilon health, inc.
Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 1831097 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY2.0%
TTM net income YoY71.7%
TTM EPS YoY73.5%
Revenue 3-yr CAGR15.0%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-2.6%
Net margin-1.5%
FCF margin-0.3%
EBITDA margin-2.1%
Returns
ROE-29.7%
ROA-5.5%
ROIC (approx.)-79.4%
Asset turnover3.80x
Leverage & solvency
Liabilities / assets82.1%
Debt / equity0.11x
Current ratio1.13x
Interest coverage-22.38x
Cash quality & payout
Operating cash flow / net income0.05x
Accruals ratio-5.2%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $5.93B | $6.06B | $4.32B | $2.39B | $1.52B |
| SG&A expense | $238.54M | $268.91M | $285.76M | $207.79M | $427.50M |
| Operating income | -$463.24M | -$292.13M | -$232.13M | -$105.38M | -$372.24M |
| Interest expense | $6.64M | $6.18M | $6.66M | $4.48M | $6.15M |
| Pretax income | -$404.10M | -$248.83M | -$194.46M | -$90.67M | -$382.98M |
| Income tax | $1.25M | $1.45M | $791,000 | $1.64M | $886,000 |
| Net income | -$391.35M | -$260.15M | -$262.60M | -$106.55M | -$406.49M |
| EBITDA | -$434.64M | -$267.67M | -$211.97M | -$91.61M | -$357.57M |
| EPS (diluted) | — | — | — | — | — |
| Weighted avg. shares (diluted) | 413.97M | 410.97M | 408.92M | 408.15M | 372.93M |
| Balance sheet | |||||
| Cash & equivalents | $173.71M | $188.23M | $114.33M | $475.91M | $1.05B |
| Short-term investments | — | — | — | $411.90M | $0 |
| Receivables | $673.79M | $1.02B | $942.46M | $492.36M | $293.41M |
| Current assets | $1.10B | $1.46B | $1.48B | $1.45B | $1.37B |
| PP&E, net | $25.42M | $28.17M | $27.58M | $19.94M | $9.16M |
| Goodwill | $0 | $24.13M | $24.13M | $2.51M | $41.54M |
| Intangibles | $65.72M | $72.77M | $63.77M | $18.45M | $55.40M |
| Total assets | $1.27B | $1.73B | $1.74B | $1.70B | $1.59B |
| Current liabilities | $1.08B | $1.15B | $977.16M | $535.09M | $356.96M |
| Short-term debt | $19.24M | $0 | $6.25M | $5.00M | $5.00M |
| Long-term debt | $15.75M | $34.90M | $32.31M | $38.48M | $43.40M |
| Total debt | $34.99M | $34.90M | $38.56M | $43.48M | $48.40M |
| Total liabilities | $1.14B | $1.26B | $1.08B | $656.86M | $494.66M |
| Shareholders' equity | $126.73M | $470.95M | $661.84M | $1.04B | $1.09B |
| Net debt | -$138.72M | -$153.33M | -$75.77M | -$432.43M | -$1.00B |
| Shares outstanding | 16.59M | 412.19M | 406.39M | 412.38M | 400.10M |
| Cash flow statement | |||||
| Operating cash flow | -$105.76M | -$57.78M | -$156.20M | -$130.81M | -$148.16M |
| Capital expenditure | $13.24M | $13.25M | $15.83M | $15.43M | $6.56M |
| Free cash flow | -$119.00M | -$71.03M | -$172.03M | -$146.23M | -$154.72M |
| Investing cash flow | $88.61M | $139.89M | -$44.02M | -$444.39M | -$90.51M |
| Financing cash flow | -$2.99M | -$2.58M | -$193.13M | $28.06M | $1.15B |
| Depreciation & amortization | $28.59M | $24.46M | $20.16M | $13.77M | $14.67M |
| Stock-based compensation | $49.12M | $50.66M | $69.50M | $28.38M | $292.39M |
| Share buybacks | — | — | $200.00M | — | — |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.